Radiosensitizing effect of the histone acetyltransferase inhibitor anacardic acid on various mammalian cell lines

ten Cate,Rosemarie; Krawczyk,Przemek; Stap,Jan; Aten,Jacob A.; Franken,Nicolaas A.P.

doi:10.3892/ol_00000134

Radiosensitizing effect of the histone acetyltransferase inhibitor anacardic acid on various mammalian cell lines

Authors:
- Rosemarie ten Cate
- Przemek Krawczyk
- Jan Stap
- Jacob A. Aten
- Nicolaas A.P. Franken
View Affiliations

Affiliations: Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental Molecular Medicine, Department of Radiation Oncology, 1100 DE Amsterdam, The Netherlands. r.tencate@amc.uva.nl
Published online on: July 1, 2010 https://doi.org/10.3892/ol_00000134
Pages: 765-769

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Agents that enhance the effectiveness of ionizing radiation have been investigated over many decades. A relatively new group of potential radiosensitizers consists of agents that inhibit histone acetyltransferases (HATs). This study evaluated the radiosensitizing properties of the HAT inhibitor anacardic acid (AA), used at a low-toxic concentration of 100 µM in V79, SW1573 and U2OS cells. Radiation survival curves were analyzed according to the linear quadratic model. Significant radiosensitization by AA was only obtained in U2OS cells. AA significantly increased the value of the linear parameter α, but not of the quadratic parameter β, indicating fixation of potentially lethal damage and an intact repair function of sublethal damage. The increase of the α value was also observed in SW1573 cells, but was not accompanied by a significant radiosensitization. A likely explanation for the enhancement of the α value may be an increase in the amount of lethal lesions due to the compacted chromatin structure. Despite the conflicting results of the radiosensitizing effect of AA in the three cell lines tested, the ability of AA to increase the α value suggests potential advantages for clinical application.

View Figures

View References

1	Joiner M, van der Kogel A and Steel G: Introduction: the significance of radiobiology and radiotherapy for cancer treatment. Basic Clinical Radiobiology. 4th edition. Joiner and van der Kogel A: University Press/Hodder; Arnold, Oxford: pp. 1–10. 2009, View Article : Google Scholar
2	Haveman J, Castro Kreder N, Rodermond HM, Franken NA, Stalpers LJ, Zdzienicka MZ and Peters GJ: Cellular response of X-ray sensitive hamster mutant cell lines to gemcitabine, cisplatin and 5-fluorouracil. Oncol Rep. 12:187–192. 2004.PubMed/NCBI
3	Bergs JWJ, Franken NA, ten Cate R, van Bree C and Haveman J: Effect of cisplatin and gamma irradiation on cell survival, the induction of chromosomal aberrations and apoptosis in SW-1573 cells. Mutat Res. 594:148–154. 2006. View Article : Google Scholar : PubMed/NCBI
4	Bergs JWJ, Franken NA, Haveman J, Geijsen ED, Crezee J and van Bree C: Hyperthermia, cisplatin and radiation trimodality treatment: a promising cancer treatment? A review from preclinical studies to clinical application. Int J Hyperthermia. 23:329–341. 2007. View Article : Google Scholar
5	Franken NA, van Bree C, Kipp JBA and Barendsen GW: Modification of potentially lethal damage in irradiated Chinese hamster V79 cells after incorporation of halogenated pyrimidines. Int J Radiat Biol. 72:101–109. 1997. View Article : Google Scholar : PubMed/NCBI
6	Franken NA, van Bree C, Veltmaat MAT, Rodermond HM, Haveman J and Barendsen GW: Radiosensitization by bromodeoxyuridine and hyperthermia: Analysis of linear and quadratic parameters of radiation survival curves of two human tumor cell lines. J Radiat Res. 42:179–190. 2001. View Article : Google Scholar : PubMed/NCBI
7	Iliakes G, Pantelias and Okayasu R: Mechanism of radiosensitization by halogenated pyrimidines: effect of BrdU on radiation induction of DNA and chromosome damage and its correlation with cell killing. Radiat Res. 119:286–304. 1989. View Article : Google Scholar : PubMed/NCBI
8	Franken NA, van Bree C, Veltmaat MA, Ludwików G, Kipp JB and Barendsen GW: Increased chromosome exchange frequencies in iodo-deoxyuridine-sensitized human SW-1573 cells after γ-irradiation. Oncol Rep. 6:59–63. 1999.PubMed/NCBI
9	Squatrito M, Gorrini C and Amati B: Tip60 in DNA damage response and growth control: many tricks in one HAT. Trends Cell Biol. 16:433–442. 2006. View Article : Google Scholar : PubMed/NCBI
10	Luger K, Mäder AW, Richmond RK, Sargent DF and Richmond TJ: Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature. 389:251–260. 1997.
11	Kouzarides Tony: Chromatin modifications and their function. Cell. 128:693–705. 2007. View Article : Google Scholar : PubMed/NCBI
12	Shahbazian MD and Grunstein M: Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem. 76:75–100. 2007. View Article : Google Scholar : PubMed/NCBI
13	Kristensen LS, Nielsen HM and Hansen LL: Epigenetics and cancer treatment. Eur J Pharmacol. 625:131–142. 2009. View Article : Google Scholar : PubMed/NCBI
14	Lee KK and Workman JL: Histone acetyltransferase complexes: one size doesn’t fit all. Nat Rev Mol Cell Biol. 8:284–295. 2007.PubMed/NCBI
15	Dekker FJ and Haisma HJ: Histone acetyl transferases as emerging drug targets. Drug Discov Today. 14:942–948. 2009. View Article : Google Scholar : PubMed/NCBI
16	Balasubramanyam K, Swaminathan V, Ranganathan A and Kundu TK: Small molecule modulators of histone acetyltransferase p300. J Biol Chem. 278:19134–19140. 2003. View Article : Google Scholar : PubMed/NCBI
17	Sun Y, Jiang X, Chen S and Price BD: Inhibition of histone acetyltransferase activity by anacardic acid sensitizes tumor cells to ionizing radiation. FEBS Lett. 580:4353–4356. 2006. View Article : Google Scholar : PubMed/NCBI
18	Sun Y, Jiang X, Chen S, Fernandes N and Price BD: A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. Proc Natl Acad Sci. 102:13182–13187. 2005. View Article : Google Scholar : PubMed/NCBI
19	Ikura T, Ogryzko VV, Grigoriev M, Groisman R, Wang J, Horikoshi M, Scully R, Qin J and Nakatani Y: Involvement of the Tip60 histone acetylase complex in DNA repair and apoptosis. Cell. 102:463–473. 2000. View Article : Google Scholar : PubMed/NCBI
20	Goodarzi AA, Noon AT and Jeggo PA: The impact of heterochromatin on DSB repair. Biochem Soc Trans. 37:569–576. 2009. View Article : Google Scholar : PubMed/NCBI
21	Biade S, Stobbe CC, Boyd JT and Chapman JD: Chemical agents that promote chromatin compaction radiosensitize tumour cells. Int J Radiat Biol. 77:1033–1042. 2001. View Article : Google Scholar : PubMed/NCBI
22	Franken NA, Rodermond HR, Stap J, Haveman J and van Bree C: Clonogenic assay of cells in vitro. Nat Protoc. 1:2315–2319. 2006. View Article : Google Scholar : PubMed/NCBI
23	Barendsen GW: Parameters of linear-quadratic radiation dose-effect relationships: dependence on LET and mechanisms of reproductive cell death. Int J Radiat Biol. 71:649–655. 1997. View Article : Google Scholar : PubMed/NCBI
24	Barendsen GW, van Bree C and Franken NA: Importance of cell proliferative state and potentially lethal damage repair on radiation effectiveness: implications for combined tumor treatments. Int J Oncol. 19:247–256. 2001.
25	Song S, McCann KE and Brown JM: Radiosensitization of yeast cells by inhibition of histone H4 acetylation. Radiat Res. 170:618–627. 2008. View Article : Google Scholar : PubMed/NCBI
26	Bandyopadhyay K, Banères JL, Martin A, Blonski C, Parello J and Gjerset RA: Spermidinyl-CoA-based HAT inhibitors block DNA repair and provide cancer-specific chemo- and radiosensitization. Cell Cycle. 8:2779–2788. 2009. View Article : Google Scholar : PubMed/NCBI